Tag:
outsourcing
Latest Headlines
Latest Headlines
AMRI gets 'smart' with its contract services
By launching what it calls SmartSourcing, the Albany CRMO hopes to provide clients with insourcing and outsourcing opportunities that lead to high-quality performance and scientific expertise without breaking the bank.
Flexibility, understanding key for CRO and pharma trust, study says
A report authored by Booz & Co. and Irish CRO Icon looks at how CROs and big pharma companies can improve working relations...
FDA builds program for outsourcing foreign plant inspections
The FDA likes the look of a program to outsource inspections, but it's caught in one of those pressure sandwiches between competing congressional concerns.
Growing popularity of virtual biotechs promises boon to outsourcers
News that tiny FerroKin BioSciences earned a big buyout deal with Shire ($SHPGY) has helped spotlight the growing popularity of the virtual biotech model.
Big quarterly loss whacks ex-Biogen chief's CMO amid transition
Wait until the second half of the fiscal year was Patheon ($PTI) CEO Jim Mullen's message after the contract drugmaker reported a $20.9 million loss.
Devicemakers eye outsourcing to limit hit from Obama tax
The medical device industry has waged war on a new tax on device makers as part of Obama's healthcare reform, and companies have begun talking up plans to outsource manufacturing work overseas as a result of the tax.
Survey: Look for strong growth in R&D outsourcing, shift to India and China
If there's one dominant theme in biotechnology these days, it's the relentless effort to cut costs and outsource work in an attempt to achieve an optimum level of efficiency. And a new survey...
Shanghai-based CRO Newsummit outlines $80M IPO
Shanghai-based Newsummit Biopharma, a fledging CRO, has filed to go public with plans to raise $80 million in the U.S. for its clinical trial services organization
Premier boosts capacity for outpatient trials
Premier Research--one of the largest CRO operations around--is expanding so it can handle outpatient trials for the first time and also keep patients overnight to boost its pharmacokinetic sampling...
Ex-AstraZeneca researchers launch new CRO
Big Pharma's bid to shed in-house drug development continues to create turmoil for the thousands of scientists who have lost or will lose their jobs as the industry streamlines. But rather than...
